Acta Pharmacologica Sinica 2003-10-01

Pharmacokinetic-pharmacodynamic modeling of daurisoline and dauricine in beagle dogs.

Shao-Jun Shi, Hui Chen, Shi-Fen Gu, Fan-Dian Zeng

Index: Acta Pharmacol. Sin. 24(10) , 1011-5, (2003)

Full Text: HTML

Abstract

To study the combined pharmacokinetic-pharmacodynamic (PK-PD) model of daurisoline and dauricine, and compare their effects on cardiac electrophsiology, blood pressure, and hemodynamics in beagle dogs.The plasma drug concentration was determined by the reversed-phase HPLC method and the effects on cardiac and hemodynamics were recorded by polygraph. The pharmacokinetic and PK-PD model parameters were calculated.The pharmacokinetics were best fitted to a two-compartment open model, and the relationship between effect and effect compartment concentration of both drugs could be represented by the sigmoid-E(max) model. There were no significant differences in main pharmacokinetics and PK-PD parameters between the two drugs.No statistically different kinetic disposition characteristics and potencies of inhibitory effects on myocardial function of daurisoline and dauricine were found in beagle dogs.

Related Compounds

  • Daurisoline

Related Articles:

Effects of daurisoline on intracellular Ca2+ activity in myocardium.

1996-05-01

[Zhongguo Yao Li Xue Bao 17(3) , 248-51, (1996)]

Effects of the putative P-type calcium channel blocker, R,R-(-)-daurisoline on neurotransmitter release.

1995-12-01

[Naunyn Schmiedebergs Arch. Pharmacol. 352(6) , 670-8, (1995)]

Daurisoline derivatives inhibit the ability of calmodulin to stimulate cyclic nucleotide phosphodiesterase activity.

1990-01-01

[Cell. Signal. 2(4) , 353-7, (1990)]

Effects of l-daurisoline on quinolinic acid-induced Ca2+ influx in hippocampus neurons in freely moving rats.

1991-07-01

[Zhongguo Yao Li Xue Bao 12(4) , 301-4, (1991)]

P-type calcium channels are blocked by the alkaloid daurisoline.

1994-07-21

[Neuroreport 5(12) , 1489-92, (1994)]

More Articles...